Vascular Risk and <b>β</b>‐Amyloid Are Synergistically Associated with Cortical Tau
Jennifer S. Rabin(Sunnybrook Health Science Centre), Jasmeer P. Chhatwal(Harvard University), Emily Kilpatrick(Harvard University), Dylan Kirn(Brigham and Women's Hospital), Rachel F. Buckley(Harvard University), Wai‐Ying Wendy Yau(Massachusetts General Hospital), Bernard Hanseeuw(Cliniques Universitaires Saint-Luc), Jennifer R. Gatchel(Harvard University), Gad A. Marshall, Hyun‐Sik Yang(Broad Institute), Anand Viswanathan(Harvard University), Trey Hedden(Harvard University), Hannah L. Klein(Harvard University), Dorene M. Rentz(Brigham and Women's Hospital), Vaishnavi Rao(Mayo Clinic), Reisa A. Sperling(Harvard University), Keith A. Johnson(Brigham and Women's Hospital), Aaron P. Schultz(Harvard University)
Cited by 107
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k